These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
333 related items for PubMed ID: 26917195
1. The impact of B-type natriuretic peptide levels on the suppression of accompanying atrial fibrillation in Wolff-Parkinson-White syndrome patients after accessory pathway ablation. Kawabata M, Goya M, Takagi T, Yamashita S, Iwai S, Suzuki M, Takamiya T, Nakamura T, Hayashi T, Yagishita A, Sasaki T, Takahashi Y, Ono Y, Hachiya H, Yamauchi Y, Otomo K, Nitta J, Okishige K, Nishizaki M, Iesaka Y, Isobe M, Hirao K. J Cardiol; 2016 Dec; 68(6):485-491. PubMed ID: 26917195 [Abstract] [Full Text] [Related]
2. Effect of pulmonary vein isolation on atrial fibrillation recurrence after accessory pathway ablation in patients with Wolff-Parkinson-White syndrome. Wu JT, Zhao DQ, Li FF, Zhang LM, Hu J, Fan XW, Hu GL, Yang HT, Yan LJ, Liu JJ, Xu XJ, Wang SL, Chu YJ. Clin Cardiol; 2020 Dec; 43(12):1511-1516. PubMed ID: 33002216 [Abstract] [Full Text] [Related]
3. Early repolarization in the inferior leads after accessory pathway ablation is highly correlated with atrial fibrillation in Wolff-Parkinson-White syndrome. Chen M, Wang Q, Sun J, Zhang PP, Li W, Mo BF, Li YG. J Cardiol; 2020 Mar; 75(3):323-329. PubMed ID: 31445855 [Abstract] [Full Text] [Related]
4. Radiofrequency ablation of accessory pathways in patients with the Wolff-Parkinson-White syndrome: the long-term mortality and risk of atrial fibrillation. Borregaard R, Lukac P, Gerdes C, Møller D, Mortensen PT, Pedersen L, Nielsen JC, Jensen HK. Europace; 2015 Jan; 17(1):117-22. PubMed ID: 25013013 [Abstract] [Full Text] [Related]
5. Addition of B-Type Natriuretic Peptide to Existing Clinical Risk Scores Enhances Identification of Patients at Risk for Atrial Fibrillation Recurrence After Pulmonary Vein Isolation. Shaikh AY, Esa N, Martin-Doyle W, Kinno M, Nieto I, Floyd KC, Browning C, Ennis C, Donahue JK, Rosenthal LS, McManus DD. Crit Pathw Cardiol; 2015 Dec; 14(4):157-65. PubMed ID: 26569657 [Abstract] [Full Text] [Related]
6. [Recurrence of atrial fibrillation after successful radiofrequency catheter ablation of accessory pathway in patients with Wolff-Parkinson-White syndrome]. Mujović N, Grujić M, Mrdja S, Kocijancić A, Vujisić-Tesić B, Petrović M, Potpara T, Mujović N. Srp Arh Celok Lek; 2010 Dec; 138(3-4):170-6. PubMed ID: 20499496 [Abstract] [Full Text] [Related]
7. Prognostic Significance and Risk of Atrial Fibrillation of Wolff-Parkinson-White Syndrome in Patients With Hypertrophic Cardiomyopathy. Song C, Guo Y, Zheng X, Lu J, Fang X, Wang S, Huang X. Am J Cardiol; 2018 Nov 01; 122(9):1546-1550. PubMed ID: 30201118 [Abstract] [Full Text] [Related]
8. Predictive value of B-type natriuretic peptide levels in patients with paroxysmal and persistent atrial fibrillation undergoing pulmonary vein isolation. Degener S, Pattberg SV, Feuersenger H, Bansmann PM, Shin DI, Krummenauer F, Horlitz M. J Interv Card Electrophysiol; 2011 Apr 01; 30(3):217-25. PubMed ID: 21249437 [Abstract] [Full Text] [Related]
9. [Does radiofrequency ablation of the bundle of Kent results in a lower risk of atrial fibrillation?]. Brembilla-Perrot B, Beurrier D, Houriez P. Arch Mal Coeur Vaiss; 2002 Feb 01; 95(2):93-6. PubMed ID: 11933545 [Abstract] [Full Text] [Related]
10. Dependency on atrial electrophysiological properties of appearance of paroxysmal atrial fibrillation in patients with Wolff-Parkinson-White syndrome: evidence from atrial vulnerability before and after radiofrequency catheter ablation and surgical cryoablation. Muraoka Y, Karakawa S, Yamagata T, Matsuura H, Kajiyama G. Pacing Clin Electrophysiol; 1998 Feb 01; 21(2):438-46. PubMed ID: 9507546 [Abstract] [Full Text] [Related]
11. Plasma atrial natriuretic Peptide and brain natriuretic Peptide levels after radiofrequency catheter ablation of atrial fibrillation. Yamada T, Murakami Y, Okada T, Okamoto M, Shimizu T, Toyama J, Yoshida Y, Tsuboi N, Ito T, Muto M, Kondo T, Inden Y, Hirai M, Murohara T. Am J Cardiol; 2006 Jun 15; 97(12):1741-4. PubMed ID: 16765125 [Abstract] [Full Text] [Related]
12. Atrial fibrillation in patients with Wolff-Parkinson-White syndrome: role of pulmonary veins. Derejko P, Szumowski LJ, Sanders P, Krupa W, Bodalski R, Orczykowski M, Urbanek P, Zakrzewska J, Lim HS, Lau DH, Kuśnierz J, Walczak F. J Cardiovasc Electrophysiol; 2012 Mar 15; 23(3):280-6. PubMed ID: 22035173 [Abstract] [Full Text] [Related]
13. Wolff-Parkinson-White syndrome in the elderly: clinical and electrophysiological findings. Brembilla-Perrot B, Yangni N'da O, Huttin O, Chometon F, Groben L, Christophe C, Benzaghou N, Luporsi JD, Tatar C, Bertrand J, Ammar S, Cedano G, Zhang N, Beurrier D. Arch Cardiovasc Dis; 2008 Jan 15; 101(1):18-22. PubMed ID: 18391868 [Abstract] [Full Text] [Related]
14. Mechanisms for atrial fibrillation in patients with Wolff-Parkinson-White syndrome. Hamada T, Hiraki T, Ikeda H, Kubara I, Yoshida T, Ohga M, Imaizumi T. J Cardiovasc Electrophysiol; 2002 Mar 15; 13(3):223-9. PubMed ID: 11942586 [Abstract] [Full Text] [Related]
15. Assessment of atrial fibrillation and vulnerability in patients with Wolff-Parkinson-White syndrome using two-dimensional speckle tracking echocardiography. Li JJ, Wei F, Chen JG, Yu YW, Gu HY, Jiang R, Wu XL, Sun Q. PLoS One; 2014 Mar 15; 9(11):e108315. PubMed ID: 25397668 [Abstract] [Full Text] [Related]
16. Impact of prophylactic cavotricuspid isthmus ablation in atrial fibrillation recurrence after a first pulmonary vein isolation procedure. Mesquita J, Ferreira AM, Cavaco D, Carmo P, Madeira M, Freitas P, Costa FM, Morgado F, Mendes M, Adragão P. Int J Cardiol; 2018 May 15; 259():82-87. PubMed ID: 29579616 [Abstract] [Full Text] [Related]
17. Radiofrequency catheter ablation of accessory pathways during pre-excited atrial fibrillation: acute success rate and long-term clinical follow-up results as compared to those patients undergoing successful catheter ablation during sinus rhythm. Kose S, Amasyali B, Aytemir K, Can I, Kilic A, Kursaklioglu H, Iyisoy A, Isik E. Heart Vessels; 2005 Jul 15; 20(4):142-6. PubMed ID: 16025362 [Abstract] [Full Text] [Related]
18. Ablation of Persistent Atrial Fibrillation Targeting Low-Voltage Areas With Selective Activation Characteristics. Jadidi AS, Lehrmann H, Keyl C, Sorrel J, Markstein V, Minners J, Park CI, Denis A, Jaïs P, Hocini M, Potocnik C, Allgeier J, Hochholzer W, Herrera-Siklody C, Kim S, Omri YE, Neumann FJ, Weber R, Haïssaguerre M, Arentz T. Circ Arrhythm Electrophysiol; 2016 Mar 15; 9(3):. PubMed ID: 26966286 [Abstract] [Full Text] [Related]
19. Pre-ablation levels of brain natriuretic peptide are independently associated with the recurrence of atrial fibrillation after radiofrequency catheter ablation in patients with nonvalvular atrial fibrillation. Miake J, Kato M, Ogura K, Iitsuka K, Okamura A, Tomomori T, Tsujimoto D, Kato M, Yamamoto K. Heart Vessels; 2019 Mar 15; 34(3):517-526. PubMed ID: 30238353 [Abstract] [Full Text] [Related]
20. Accessory pathway ablation during atrial fibrillation in Ebstein anomaly. Miyamoto T, Oginosawa Y, Yagyu K, Yamagishi Y, Tsukahara K, Ohe H, Kohno R, Abe H, Kataoka M. Pacing Clin Electrophysiol; 2022 Mar 15; 45(3):431-434. PubMed ID: 34752651 [Abstract] [Full Text] [Related] Page: [Next] [New Search]